INTERNATIONAL PATENT: SCIENTIAM PHARMA, ZHONG, QIAN FILES APPLICATION FOR "HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OR THE PREVENTION OF EBV-ASSOCIATED DISORDERS"

GENEVA, June 12 -- SCIENTIAM PHARMA (9 Rue Campagne Premiere, Paris75014), ZHONG, Qian (Sun Yat-sen University Cancer Center, 651 Dong Feng Road, EastGuangzhou, Guangdong 510060) filed a patent application (PCT/CN2024/135702) for "HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OR THE PREVENTION OF EBV-ASSOCIATED DISORDERS" on Nov 29, 2024. With publication no. WO/2025/113647, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GALONS, Herve (Scientiam Pharma, 9, Rue Campagne Premiere, Paris75014), OUMATA, Nassima (Sc...